{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:35:49Z","timestamp":1785803749822,"version":"3.56.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11926-018-0778-5","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T05:03:05Z","timestamp":1536555785000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Hypophosphatasia: From Diagnosis to Treatment"],"prefix":"10.1007","volume":"20","author":[{"given":"Sebastian","family":"Simon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Resch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Klaushofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Roschger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Zwerina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Kocijan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"issue":"10","key":"778_CR1","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/jbmr.3226","volume":"32","author":"JR Shapiro","year":"2017","unstructured":"\u2022 Shapiro JR, Lewiecki EM. Hypophosphatasia in adults: clinical assessment and treatment considerations. J Bone Miner Res. 2017;32(10):1977\u201380. https:\/\/doi.org\/10.1002\/jbmr.3226 . Treatment considerations for adults with HPP","journal-title":"J Bone Miner Res"},{"issue":"6","key":"778_CR2","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/archpedi.1948.02030020840003","volume":"75","author":"JC Rathbun","year":"1948","unstructured":"Rathbun JC. Hypophosphatasia; a new developmental anomaly. Am J Dis Child. 1948;75(6):822\u201331.","journal-title":"Am J Dis Child"},{"issue":"4","key":"778_CR3","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/jbmr.3075","volume":"32","author":"MP Whyte","year":"2017","unstructured":"\u2022\u2022 Whyte MP. Hypophosphatasia: enzyme replacement therapy brings new opportunities and new challenges. J Bone Miner Res. 2017;32(4):667\u201375. https:\/\/doi.org\/10.1002\/jbmr.3075 . Reviews the enzyme replacement therapy asfotase alfa for HPP","journal-title":"J Bone Miner Res"},{"issue":"4","key":"778_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00223-015-0079-1","volume":"98","author":"JL Millan","year":"2016","unstructured":"Millan JL, Whyte MP. Alkaline phosphatase and hypophosphatasia. Calcif Tissue Int. 2016;98(4):398\u2013416. https:\/\/doi.org\/10.1007\/s00223-015-0079-1 .","journal-title":"Calcif Tissue Int"},{"issue":"Suppl 2","key":"778_CR5","first-page":"380","volume":"10","author":"C Rockman-Greenberg","year":"2013","unstructured":"Rockman-Greenberg C. Hypophosphatasia. Pediatr Endocrinol Rev. 2013;10(Suppl 2):380\u20138.","journal-title":"Pediatr Endocrinol Rev"},{"key":"778_CR6","unstructured":"Rajesh V. Thakker MPW, John A. Eisman, Takashi Igarashi. Genetics of bone biology and skeletal disease. 31st October 2017. p. 481\u2013500."},{"issue":"4","key":"778_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrendo.2016.14","volume":"12","author":"MP Whyte","year":"2016","unstructured":"\u2022 Whyte MP. Hypophosphatasia\u2014aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016;12(4):233\u201346. https:\/\/doi.org\/10.1038\/nrendo.2016.14 . Summarizes the pathogenesis, diagnosis, and treatment of HPP.","journal-title":"Nat Rev Endocrinol"},{"key":"778_CR8","volume-title":"Genetics of bone biology and skeletal disease. 2nd ed","author":"MW RV Thakker","year":"2017","unstructured":"RV Thakker MW, Eisman J, Igarashi T. Genetics of bone biology and skeletal disease. 2nd ed. New York: Elsevier; 2017."},{"issue":"4","key":"778_CR9","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/jbmr.2110.","volume":"29","author":"N Guanabens","year":"2014","unstructured":"Guanabens N, Mumm S, Moller I, Gonzalez-Roca E, Peris P, Demertzis JL, et al. Calcific periarthritis as the only clinical manifestation of hypophosphatasia in middle-aged sisters. J Bone Miner Res. 2014;29(4):929\u201334. https:\/\/doi.org\/10.1002\/jbmr.2110.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"778_CR10","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/0002-9343(57)90124-9","volume":"22","author":"D Fraser","year":"1957","unstructured":"Fraser D. Hypophosphatasia. Am J Med. 1957;22(5):730\u201346.","journal-title":"Am J Med"},{"issue":"3","key":"778_CR11","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/archdischild-2013-305037","volume":"99","author":"T Taketani","year":"2014","unstructured":"Taketani T, Onigata K, Kobayashi H, Mushimoto Y, Fukuda S, Yamaguchi S. Clinical and genetic aspects of hypophosphatasia in Japanese patients. Arch Dis Child. 2014;99(3):211\u20135. https:\/\/doi.org\/10.1136\/archdischild-2013-305037 .","journal-title":"Arch Dis Child"},{"issue":"4","key":"778_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1055\/s-0029-1220718.","volume":"221","author":"C Beck","year":"2009","unstructured":"Beck C, Morbach H, Stenzel M, Schneider P, Collmann H, Girschick G, et al. Hypophosphatasia. Klin Padiatr. 2009;221(4):219\u201326. https:\/\/doi.org\/10.1055\/s-0029-1220718.","journal-title":"Klin Padiatr"},{"issue":"3","key":"778_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/j.1469-1809.2011.00642.x","volume":"75","author":"E Mornet","year":"2011","unstructured":"Mornet E, Yvard A, Taillandier A, Fauvert D, Simon-Bouy B. A molecular-based estimation of the prevalence of hypophosphatasia in the European population. Ann Hum Genet. 2011;75(3):439\u201345. https:\/\/doi.org\/10.1111\/j.1469-1809.2011.00642.x .","journal-title":"Ann Hum Genet"},{"key":"778_CR14","volume-title":"Hypophosphatasia","author":"E Mornet","year":"1993","unstructured":"Mornet E, Nunes ME. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, LJH B, Stephens K, et al., editors. Hypophosphatasia. Seattle (WA): GeneReviews((R)); 1993."},{"issue":"9","key":"778_CR15","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1359\/jbmr.2001.16.9.1724.","volume":"16","author":"S Mumm","year":"2001","unstructured":"Mumm S, Jones J, Finnegan P, Whyte MP. Hypophosphatasia: molecular diagnosis of Rathbun\u2019s original case. J Bone Miner Res. 2001;16(9):1724\u20137. https:\/\/doi.org\/10.1359\/jbmr.2001.16.9.1724.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"778_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1006\/geno.1993.1305","volume":"17","author":"CR Greenberg","year":"1993","unstructured":"Greenberg CR, Taylor CL, Haworth JC, Seargeant LE, Philipps S, Triggs-Raine B, et al. A homoallelic Gly317-->Asp mutation in ALPL causes the perinatal (lethal) form of hypophosphatasia in Canadian mennonites. Genomics. 1993;17(1):215\u20137. https:\/\/doi.org\/10.1006\/geno.1993.1305 .","journal-title":"Genomics"},{"issue":"7410","key":"778_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(65)91422-4","volume":"2","author":"RG Russell","year":"1965","unstructured":"Russell RG. Excretion of inorganic pyrophosphate in hypophosphatasia. Lancet. 1965;2(7410):461\u20134.","journal-title":"Lancet"},{"key":"778_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-2-40","volume":"2","author":"E Mornet","year":"2007","unstructured":"Mornet E. Hypophosphatasia. Orphanet J Rare Dis. 2007;2:40. https:\/\/doi.org\/10.1186\/1750-1172-2-40 .","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"778_CR19","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1359\/jbmr.071213.","volume":"23","author":"JL Millan","year":"2008","unstructured":"Millan JL, Narisawa S, Lemire I, Loisel TP, Boileau G, Leonard P, et al. Enzyme replacement therapy for murine hypophosphatasia. J Bone Miner Res. 2008;23(6):777\u201387. https:\/\/doi.org\/10.1359\/jbmr.071213.","journal-title":"J Bone Miner Res"},{"issue":"4","key":"778_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1210\/edrv-15-4-439","volume":"15","author":"MP Whyte","year":"1994","unstructured":"Whyte MP. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev. 1994;15(4):439\u201361. https:\/\/doi.org\/10.1210\/edrv-15-4-439 .","journal-title":"Endocr Rev"},{"issue":"6855","key":"778_CR21","first-page":"131","volume":"268","author":"CR Mc","year":"1955","unstructured":"Mc CR, Morrison AB, Dent CE. The excretion of phosphoethanolamine and hypophosphatasia. Lancet. 1955;268(6855):131.","journal-title":"Lancet"},{"issue":"1","key":"778_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0002-9343(78)90189-4","volume":"64","author":"AA Licata","year":"1978","unstructured":"Licata AA, Radfar N, Bartter FC, Bou E. The urinary excretion of phosphoethanolamine in diseases other than hypophosphatasia. Am J Med. 1978;64(1):133\u20138.","journal-title":"Am J Med"},{"issue":"1","key":"778_CR23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/j.1749-6632.1958.tb36875.x","volume":"75","author":"N Kretchmer","year":"1958","unstructured":"Kretchmer N, Stone M, Bauer C. Hereditary enzymatic effects as illustrated by hypophosphatasia. Ann N Y Acad Sci. 1958;75(1):279\u201385.","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 2","key":"778_CR24","first-page":"S73","volume":"36","author":"B Plecko","year":"2009","unstructured":"Plecko B, Stockler S. Vitamin B6 dependent seizures. Can J Neurol Sci. 2009;36(Suppl 2):S73\u20137.","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"778_CR25","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1172\/JCI112031.","volume":"76","author":"MP Whyte","year":"1985","unstructured":"Whyte MP, Mahuren JD, Vrabel LA, Coburn SP. Markedly increased circulating pyridoxal-5\u2032-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism. J Clin Invest. 1985;76(2):752\u20136. https:\/\/doi.org\/10.1172\/JCI112031.","journal-title":"J Clin Invest"},{"key":"778_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1750-1172-4-6","volume":"4","author":"A Reibel","year":"2009","unstructured":"Reibel A, Maniere MC, Clauss F, Droz D, Alembik Y, Mornet E, et al. Orodental phenotype and genotype findings in all subtypes of hypophosphatasia. Orphanet J Rare Dis. 2009;4:6. https:\/\/doi.org\/10.1186\/1750-1172-4-6 .","journal-title":"Orphanet J Rare Dis."},{"key":"778_CR27","unstructured":"The tissue nonspecific alkaline phosphatase gene mutations database [database on the Internet] last update February 25, 2018. Available from: http:\/\/www.sesep.uvsq.fr\/03_hypo_mutations.php . Accessed: 05.03.2018."},{"issue":"3","key":"778_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1055\/s-0029-1214353","volume":"16","author":"SM BeckC","year":"2009","unstructured":"BeckC SM, Schneider P, Girschick HJ. Hypophosphatasie\u2014aktuelle Diagnostik und Therapie. J Mineralstoffwechsel. 2009;16(3):116\u201322. https:\/\/doi.org\/10.1055\/s-0029-1214353 .","journal-title":"J Mineralstoffwechsel"},{"issue":"3","key":"778_CR29","first-page":"164","volume":"8","author":"JL Millan","year":"2012","unstructured":"Millan JL, Plotkin H. Hypophosphatasia\u2014pathophysiology and treatment. Actual osteol. 2012;8(3):164\u201382.","journal-title":"Actual osteol"},{"issue":"6","key":"778_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1600-0714.1996.tb00274.x","volume":"25","author":"A Olsson","year":"1996","unstructured":"Olsson A, Matsson L, Blomquist HK, Larsson A, Sjodin B. Hypophosphatasia affecting the permanent dentition. J Oral Pathol Med. 1996;25(6):343\u20137.","journal-title":"J Oral Pathol Med"},{"key":"778_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bone.2015.02.022","volume":"75","author":"MP Whyte","year":"2015","unstructured":"Whyte MP, Zhang F, Wenkert D, McAlister WH, Mack KE, Benigno MC, et al. Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients. Bone. 2015;75:229\u201339. https:\/\/doi.org\/10.1016\/j.bone.2015.02.022 .","journal-title":"Bone"},{"issue":"2","key":"778_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/jbmr.1767.","volume":"28","author":"BL Foster","year":"2013","unstructured":"Foster BL, Nagatomo KJ, Tso HW, Tran AB, Nociti FH Jr, Narisawa S, et al. Tooth root dentin mineralization defects in a mouse model of hypophosphatasia. J Bone Miner Res. 2013;28(2):271\u201382. https:\/\/doi.org\/10.1002\/jbmr.1767.","journal-title":"J Bone Miner Res"},{"key":"778_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.bone.2014.11.017","volume":"72","author":"KC Gasque","year":"2015","unstructured":"Gasque KC, Foster BL, Kuss P, Yadav MC, Liu J, Kiffer-Moreira T, et al. Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl-\/- mice by administration of soluble (non-targeted) chimeric alkaline phosphatase. Bone. 2015;72:137\u201347. https:\/\/doi.org\/10.1016\/j.bone.2014.11.017 .","journal-title":"Bone"},{"issue":"10","key":"778_CR34","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1007\/s00198-011-1528-y.","volume":"22","author":"F Barvencik","year":"2011","unstructured":"Barvencik F, Beil FT, Gebauer M, Busse B, Koehne T, Seitz S, et al. Skeletal mineralization defects in adult hypophosphatasia\u2014a clinical and histological analysis. Osteoporos Int. 2011;22(10):2667\u201375. https:\/\/doi.org\/10.1007\/s00198-011-1528-y.","journal-title":"Osteoporos Int"},{"issue":"4","key":"778_CR35","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1007\/s11999-008-0123-9","volume":"466","author":"F Barvencik","year":"2008","unstructured":"Barvencik F, Gebauer M, Schinke T, Amling M. Case report: multiple fractures in a patient with mutations of TWIST1 and TNSALP. Clin Orthop Relat Res. 2008;466(4):990\u20136. https:\/\/doi.org\/10.1007\/s11999-008-0123-9 .","journal-title":"Clin Orthop Relat Res"},{"issue":"10","key":"778_CR36","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1056\/NEJMoa1106173","volume":"366","author":"MP Whyte","year":"2012","unstructured":"\u2022\u2022 Whyte MP, Greenberg CR, Salman NJ, Bober MB, McAlister WH, Wenkert D, et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. N Engl J Med. 2012;366(10):904\u201313. https:\/\/doi.org\/10.1056\/NEJMoa1106173 . Multinational, open-label study of treatment with enzyme-replacement therapy.","journal-title":"N Engl J Med"},{"issue":"7","key":"778_CR37","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2106\/00004623-198668070-00004","volume":"68","author":"JD Coe","year":"1986","unstructured":"Coe JD, Murphy WA, Whyte MP. Management of femoral fractures and pseudofractures in adult hypophosphatasia. J Bone Joint Surg Am. 1986;68(7):981\u201390.","journal-title":"J Bone Joint Surg Am"},{"issue":"7","key":"778_CR38","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1111\/j.1651-2227.2011.02228.x","volume":"100","author":"A Mohn","year":"2011","unstructured":"Mohn A, De Leonibus C, de Giorgis T, Mornet E, Chiarelli F. Hypophosphatasia in a child with widened anterior fontanelle: lessons learned from late diagnosis and incorrect treatment. Acta Paediatr. 2011;100(7):e43\u20136. https:\/\/doi.org\/10.1111\/j.1651-2227.2011.02228.x .","journal-title":"Acta Paediatr"},{"issue":"6","key":"778_CR39","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.bone.2007.01.020","volume":"40","author":"S Baumgartner-Sigl","year":"2007","unstructured":"Baumgartner-Sigl S, Haberlandt E, Mumm S, Scholl-Burgi S, Sergi C, Ryan L, et al. Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene. Bone. 2007;40(6):1655\u201361. https:\/\/doi.org\/10.1016\/j.bone.2007.01.020 .","journal-title":"Bone"},{"issue":"7","key":"778_CR40","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/ard.48.7.571","volume":"48","author":"AJ Chuck","year":"1989","unstructured":"Chuck AJ, Pattrick MG, Hamilton E, Wilson R, Doherty M. Crystal deposition in hypophosphatasia: a reappraisal. Ann Rheum Dis. 1989;48(7):571\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"778_CR41","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/adc.65.1.130","volume":"65","author":"SS Seshia","year":"1990","unstructured":"Seshia SS, Derbyshire G, Haworth JC, Hoogstraten J. Myopathy with hypophosphatasia. Arch Dis Child. 1990;65(1):130\u20131.","journal-title":"Arch Dis Child"},{"issue":"Suppl 3","key":"778_CR42","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1007\/s10545-009-9012-y.","volume":"33","author":"S Balasubramaniam","year":"2010","unstructured":"Balasubramaniam S, Bowling F, Carpenter K, Earl J, Chaitow J, Pitt J, et al. Perinatal hypophosphatasia presenting as neonatal epileptic encephalopathy with abnormal neurotransmitter metabolism secondary to reduced co-factor pyridoxal-5\u2032-phosphate availability. J Inherit Metab Dis. 2010;33(Suppl 3):S25\u201333. https:\/\/doi.org\/10.1007\/s10545-009-9012-y.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"778_CR43","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1001\/archinte.1981.00340060035010","volume":"141","author":"RS Weinstein","year":"1981","unstructured":"Weinstein RS, Whyte MP. Heterogeneity of adult hypophosphatasia. Report of severe and mild cases. Arch Intern Med. 1981;141(6):727\u201331.","journal-title":"Arch Intern Med"},{"issue":"7","key":"778_CR44","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00431-008-0835-6","volume":"168","author":"P Moulin","year":"2009","unstructured":"Moulin P, Vaysse F, Bieth E, Mornet E, Gennero I, Dalicieux-Laurencin S, et al. Hypophosphatasia may lead to bone fragility: don\u2019t miss it. Eur J Pediatr. 2009;168(7):783\u20138. https:\/\/doi.org\/10.1007\/s00431-008-0835-6 .","journal-title":"Eur J Pediatr"},{"issue":"9","key":"778_CR45","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s00198-017-4087-z.","volume":"28","author":"T Schmidt","year":"2017","unstructured":"Schmidt T, Mussawy H, Rolvien T, Hawellek T, Hubert J, Ruther W, et al. Clinical, radiographic and biochemical characteristics of adult hypophosphatasia. Osteoporos Int. 2017;28(9):2653\u201362. https:\/\/doi.org\/10.1007\/s00198-017-4087-z.","journal-title":"Osteoporos Int"},{"key":"778_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2015.59.","volume":"3","author":"A Nakamura-Takahashi","year":"2016","unstructured":"Nakamura-Takahashi A, Miyake K, Watanabe A, Hirai Y, Iijima O, Miyake N, et al. Treatment of hypophosphatasia by muscle-directed expression of bone-targeted alkaline phosphatase via self-complementary AAV8 vector. Mol Ther Methods Clin Dev. 2016;3:15059. https:\/\/doi.org\/10.1038\/mtm.2015.59.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"4","key":"778_CR47","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/clinchem\/35.4.664","volume":"35","author":"G Lum","year":"1989","unstructured":"Lum G, Marquardt C, Khuri SF. Hypomagnesemia and low alkaline phosphatase activity in patients' serum after cardiac surgery. Clin Chem. 1989;35(4):664\u20137.","journal-title":"Clin Chem"},{"issue":"4","key":"778_CR48","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1172\/JCI117814.","volume":"95","author":"MP Whyte","year":"1995","unstructured":"Whyte MP, Landt M, Ryan LM, Mulivor RA, Henthorn PS, Fedde KN, et al. Alkaline phosphatase: placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5\u2032-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy. J Clin Invest. 1995;95(4):1440\u20135. https:\/\/doi.org\/10.1172\/JCI117814.","journal-title":"J Clin Invest"},{"issue":"9","key":"778_CR49","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1002\/jbmr.2495.","volume":"30","author":"T Cundy","year":"2015","unstructured":"Cundy T, Michigami T, Tachikawa K, Dray M, Collins JF, Paschalis EP, et al. Reversible deterioration in hypophosphatasia caused by renal failure with bisphosphonate treatment. J Bone Miner Res. 2015;30(9):1726\u201337. https:\/\/doi.org\/10.1002\/jbmr.2495.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"778_CR50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4274\/jcrpe.473","volume":"4","author":"H Demirbilek","year":"2012","unstructured":"Demirbilek H, Alanay Y, Alikasifoglu A, Topcu M, Mornet E, Gonc N, et al. Hypophosphatasia presenting with pyridoxine-responsive seizures, hypercalcemia, and pseudotumor cerebri: case report. J Clin Res Pediatr Endocrinol. 2012;4(1):34\u20138. https:\/\/doi.org\/10.4274\/jcrpe.473 .","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"6","key":"778_CR51","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1359\/jbmr.081253.","volume":"24","author":"MP Whyte","year":"2009","unstructured":"Whyte MP. Atypical femoral fractures, bisphosphonates, and adult hypophosphatasia. J Bone Miner Res. 2009;24(6):1132\u20134. https:\/\/doi.org\/10.1359\/jbmr.081253.","journal-title":"J Bone Miner Res"},{"issue":"12","key":"778_CR52","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s00108-016-0147-2.","volume":"57","author":"T Schmidt","year":"2016","unstructured":"Schmidt T, Amling M, Barvencik F. Hypophosphatasia: what is currently available for treatment? Internist (Berl). 2016;57(12):1145\u201354. https:\/\/doi.org\/10.1007\/s00108-016-0147-2.","journal-title":"Internist (Berl)"},{"issue":"1\u20132","key":"778_CR53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ymgme.2017.07.010","volume":"122","author":"PS Kishnani","year":"2017","unstructured":"Kishnani PS, Rush ET, Arundel P, Bishop N, Dahir K, Fraser W, et al. Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa. Mol Genet Metab. 2017;122(1\u20132):4\u201317. https:\/\/doi.org\/10.1016\/j.ymgme.2017.07.010 .","journal-title":"Mol Genet Metab"},{"key":"778_CR54","unstructured":"Franz Jakob, Christine Hofmann Knochenerkrankungen. In: Schweiz FR, Schweiz OdR, In Zusammenarbeit mit SGR, Rheumatologie SGf, editors. 2016."},{"key":"778_CR55","doi-asserted-by":"publisher","unstructured":"Bishop N. Clinical management of hypophosphatasia. Clin Cases Miner Bone Metab 2015;12(2):170\u20133. doi: https:\/\/doi.org\/10.11138\/ccmbm\/2015.12.2.170 .","DOI":"10.11138\/ccmbm\/2015.12.2.170"},{"issue":"4","key":"778_CR56","first-page":"340","volume":"138","author":"DP Speer","year":"1984","unstructured":"Speer DP. Chronic multifocal symmetrical osteomyelitis. Am J Dis Child. 1984;138(4):340.","journal-title":"Am J Dis Child."},{"issue":"8","key":"778_CR57","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1359\/jbmr.090308.","volume":"24","author":"MP Whyte","year":"2009","unstructured":"Whyte MP, Wenkert D, McAlister WH, Mughal MZ, Freemont AJ, Whitehouse R, et al. Chronic recurrent multifocal osteomyelitis mimicked in childhood hypophosphatasia. J Bone Miner Res. 2009;24(8):1493\u2013505. https:\/\/doi.org\/10.1359\/jbmr.090308.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"778_CR58","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/00005792-198401000-00002","volume":"63","author":"MD Fallon","year":"1984","unstructured":"Fallon MD, Teitelbaum SL, Weinstein RS, Goldfischer S, Brown DM, Whyte MP. Hypophosphatasia: clinicopathologic comparison of the infantile, childhood, and adult forms. Medicine (Baltimore). 1984;63(1):12\u201324.","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"778_CR59","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1210\/js.2017-00307","volume":"1","author":"H Remde","year":"2017","unstructured":"Remde H, Cooper MS, Quinkler M. Successful asfotase alfa treatment in an adult dialysis patient with childhood-onset hypophosphatasia. Journal of the Endocrine Society. 2017;1(9):1188\u201393. https:\/\/doi.org\/10.1210\/js.2017-00307 .","journal-title":"Journal of the Endocrine Society"},{"key":"778_CR60","doi-asserted-by":"publisher","unstructured":"Kishnani PS, Rockman-Greenberg C, Denker AE, Moseley S, Whyte MP. Biochemical and physical function outcomes after 5 years of treatment with asfotase alfa in adolescents and adults with hypophosphatasia: phase 2 study results. Bone Abstract. 2017;6:OC25. https:\/\/doi.org\/10.1530\/boneabs.6.OC25 .","DOI":"10.1530\/boneabs.6.OC25"},{"key":"778_CR61","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s00198-018-4613-7","volume":"29","author":"SA Bowden","year":"2018","unstructured":"Bowden SA, Adler BH. Reappearance of hypomineralized bone after discontinuation of asfotase alfa treatment for severe childhood hypophosphatasia. Osteoporos Int. 2018;29:2155\u20136. https:\/\/doi.org\/10.1007\/s00198-018-4613-7 .","journal-title":"Osteoporos Int"},{"issue":"12","key":"778_CR62","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.1210\/jc.2010-1168","volume":"95","author":"C Schalin-Jantti","year":"2010","unstructured":"Schalin-Jantti C, Mornet E, Lamminen A, Valimaki MJ. Parathyroid hormone treatment improves pain and fracture healing in adult hypophosphatasia. J Clin Endocrinol Metab. 2010;95(12):5174\u20139. https:\/\/doi.org\/10.1210\/jc.2010-1168 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"778_CR63","doi-asserted-by":"publisher","first-page":"941","DOI":"10.4158\/EP15890.OR","volume":"22","author":"PM Camacho","year":"2016","unstructured":"Camacho PM, Mazhari AM, Wilczynski C, Kadanoff R, Mumm S, Whyte MP. Adult hypophosphatasia treated with teriparatide: report of 2 patients and review of the literature. Endocr Pract. 2016;22(8):941\u201350. https:\/\/doi.org\/10.4158\/EP15890.OR .","journal-title":"Endocr Pract"},{"issue":"3","key":"778_CR64","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00223-011-9562-5","volume":"90","author":"M Laroche","year":"2012","unstructured":"Laroche M. Failure of teriparatide in treatment of bone complications of adult hypophosphatasia. Calcif Tissue Int. 2012;90(3):250. https:\/\/doi.org\/10.1007\/s00223-011-9562-5 .","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"778_CR65","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1210\/jc.2009-1965","volume":"95","author":"C Gagnon","year":"2010","unstructured":"Gagnon C, Sims NA, Mumm S, McAuley SA, Jung C, Poulton IJ, et al. Lack of sustained response to teriparatide in a patient with adult hypophosphatasia. J Clin Endocrinol Metab. 2010;95(3):1007\u201312. https:\/\/doi.org\/10.1210\/jc.2009-1965 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"778_CR66","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1172\/JCI83731.","volume":"127","author":"L Seefried","year":"2017","unstructured":"Seefried L, Baumann J, Hemsley S, Hofmann C, Kunstmann E, Kiese B, et al. Efficacy of anti-sclerostin monoclonal antibody BPS804 in adult patients with hypophosphatasia. J Clin Invest. 2017;127(6):2148\u201358. https:\/\/doi.org\/10.1172\/JCI83731.","journal-title":"J Clin Invest"},{"issue":"3","key":"778_CR67","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.bone.2007.10.021","volume":"42","author":"P Roschger","year":"2008","unstructured":"Roschger P, Paschalis EP, Fratzl P, Klaushofer K. Bone mineralization density distribution in health and disease. Bone. 2008;42(3):456\u201366. https:\/\/doi.org\/10.1016\/j.bone.2007.10.021 .","journal-title":"Bone"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-018-0778-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0778-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-018-0778-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T08:52:49Z","timestamp":1604911969000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-018-0778-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":67,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["778"],"URL":"https:\/\/doi.org\/10.1007\/s11926-018-0778-5","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,10]]},"assertion":[{"value":"10 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Roland Kocijan and Heinrich Resch reports grants from ALEXION, outside the submitted work and speaker honoraria from ALEXION.Sebastian Simon, Klaus Klaushofer, Paul Roschger, and Jochen Zwerina declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"69"}}